Skip to main content

Advertisement

Log in

Diabetische Retinopathie

Diabetic retinopathy

  • Übersichten
  • Published:
Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie Aims and scope Submit manuscript

Zusammenfassung

Die diabetische Retinopathie (DR) ist die Hauptursache für Erblindung in den Industrienationen. Nach 15- bis 20-jähriger Erkrankungsdauer sind ca. 95 % der Patienten hiervon betroffen. Neben den hohen sozioökonomischen Kosten ergeben sich verschiedene wichtige Aspekte im beruflichen Kontext. Diese Arbeit gibt eine Übersicht über den aktuellen Stand der DR hinsichtlich Epidemiologie, Pathologie, Diagnostik und Therapie sowie unter besonderer Berücksichtigung arbeitsmedizinischer Aspekte.

Abstract

Diabetic retinopathy (DR) is the main cause of blindness in industrialized countries. Approximately 95 % of all patients with diabetes will develop some degree of DR after 15–20 years duration of the disease. Besides the enormous socioeconomic costs, there are various aspects of major occupational importance. The article gives a review of the current knowledge about epidemiology, pathology, diagnostics and therapy on DR with a particular emphasis on occupational medical aspects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Aiello LP, Avery RL, Arrigg PG et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487

    Article  CAS  PubMed  Google Scholar 

  2. Aiello LP, Sun W, Das A et al (2015) Intensive diabetes therapy and ocular surgery in type 1 diabetes. N Engl J Med 372:1722–1733

    Article  PubMed  Google Scholar 

  3. Boehme MW, Buechele G, Frankenhauser-Mannuss J et al (2015) Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany – a retrospective cohort and case control study in claims data of a large statutory health insurance. BMC Public Health 15:855

    Article  PubMed Central  PubMed  Google Scholar 

  4. De Clerck EE, Schouten JS, Berendschot TT et al (2015) New ophthalmologic imaging techniques for detection and monitoring of neurodegenerative changes in diabetes: a systematic review. Lancet 3:653–663

    PubMed  Google Scholar 

  5. Fong DS, Aiello LP, Ferris FL 3rd et al (2004) Diabetic retinopathy. Diabetes Care 27:2540–2553

    Article  PubMed  Google Scholar 

  6. Hammes HP, Lemmen KD, Jochmann C et al (2006) [Diabetic retinopathy and maculopathy]. Dtsch Med Wochenschr 131:1173–1175. (1946)

    Article  PubMed  Google Scholar 

  7. Heller T, Blum M, Spraul M et al (2014) [Diabetic co-morbidities: prevalences in Germany]. Dtsch Med Wochenschr 139:786–791. (1946)

    Article  CAS  PubMed  Google Scholar 

  8. Hutchinson A, Mcintosh A, Peters J et al (2000) Effectiveness of screening and monitoring tests for diabetic retinopathy–a systematic review. Diabet Med 17:495–506

    Article  CAS  PubMed  Google Scholar 

  9. Koya D, King GL (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47:859–866

    Article  CAS  PubMed  Google Scholar 

  10. Lang GE (2007) Pharmacological treatment of diabetic retinopathy. Ophthalmologica 221:112–117

    Article  CAS  PubMed  Google Scholar 

  11. Lippmann-Grob B, Bierwirth RA, Kron P et al (2004) [Patient classification and analysis of risk profiles for type 2 diabetics as the main focus point in practice. Results of the TEMPO study]. Dtsch Med Wochenschr 129:75–81. (1946)

    Article  CAS  PubMed  Google Scholar 

  12. Mehrtens G, Valentin H, Schönberger A (2003) Arbeitsunfall und Berufskrankheit. Erich Schmidt Verlag GmbH & Co, Berlin, S 1373

    Google Scholar 

  13. Robison WG Jr, Nagata M, Laver N et al (1989) Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor. Invest Ophthalmol Vis Sci 30:2285–2292

    PubMed  Google Scholar 

  14. Singh R, Ramasamy K, Abraham C et al (2008) Diabetic retinopathy: an update. Indian J Ophthalmol 56:178–188

    Article  PubMed  Google Scholar 

  15. Strom C, Sander B, Klemp K et al (2005) Effect of ruboxistaurin on blood-retinal barrier permeability in relation to severity of leakage in diabetic macular edema. Invest Ophthalmol Vis Sci 46:3855–3858

    Article  PubMed  Google Scholar 

  16. Xia P, Aiello LP, Ishii H et al (1996) Characterization of vascular endothelial growth factor’s effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98:2018–2026

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. Schöffel.

Ethics declarations

Interessenkonflikt

N. Schöffel, N. Wahrlich, J. Bauer, M.H.K. Bendels und D.A. Groneberg geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Additional information

Diese Arbeit ist Teil eines Promotionsverfahrens von N. Wahrlich.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schöffel, N., Wahrlich, N., Bauer, J. et al. Diabetische Retinopathie. Zbl Arbeitsmed 66, 101–104 (2016). https://doi.org/10.1007/s40664-015-0082-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40664-015-0082-4

Schlüsselwörter

Keywords

Navigation